USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 3, 2022 | Jun 2022 | - | - | $-0.33 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 3, 2022 | Jun 2022 | - | - | $2.84M |
Gritstone Oncology's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $-1.46 | $-1.84 | $-1.05 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-1.46 | $-1.46 | $-1.77 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $26.49M | $10.00M | $72.95M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 4, 2022 | Mar 2022 | $-0.37 | - | - |
| Mar 10, 2022 | Dec 2021 | $-0.38 | $-0.37 | 2.63% |
| Nov 3, 2021 | Sep 2021 | $-0.58 | $-0.36 | 37.93% |
| Aug 5, 2021 | Jun 2021 | $-0.62 | $-0.33 | 46.34% |
| May 6, 2021 | Mar 2021 | $-0.58 | $0.10 | 117.39% |
| Mar 11, 2021 | Dec 2020 | $-0.61 | $-0.69 | -13.11% |
| Nov 5, 2020 | Sep 2020 | $-0.62 | $-0.69 | -11.89% |
| Aug 5, 2020 | Jun 2020 | $-0.76 | $-0.69 | 9.21% |
| May 7, 2020 | Mar 2020 | $-0.72 | $-0.71 | 1.93% |
| Mar 11, 2020 | Dec 2019 | $-0.72 | $-0.77 | -6.46% |
| Nov 12, 2019 | Sep 2019 | $-0.65 | $-0.77 | -19.07% |
| Aug 12, 2019 | Jun 2019 | $-0.59 | $-0.63 | -6.78% |
| May 13, 2019 | Mar 2019 | $-0.65 | $-0.62 | 4.13% |
| Mar 28, 2019 | Dec 2018 | $-0.63 | $-0.61 | 2.56% |
| Nov 14, 2018 | Sep 2018 | $-0.57 | $-0.84 | -46.52% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 10, 2022 | Dec 2021 | $-1.04 | $-0.96 | - |
| Mar 11, 2021 | Dec 2020 | $-2.68 | $-2.78 | - |
| Mar 11, 2020 | Dec 2019 | $-2.66 | $-2.79 | - |
| Mar 28, 2019 | Dec 2018 | $-2.31 | $-1.45 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 4, 2022 | Mar 2022 | $3.86M | - | - |
| Mar 10, 2022 | Dec 2021 | $2.86M | $-2.39M | - |
| Nov 3, 2021 | Sep 2021 | $2.24M | $2.61M | 1.17% |
| Aug 5, 2021 | Jun 2021 | $2.24M | $2.84M | 1.27% |
| May 6, 2021 | Mar 2021 | $12.21M | $39.69M | 3.25% |
| Mar 11, 2021 | Dec 2020 | $1.21M | $1.35M | 1.11% |
| Nov 5, 2020 | Sep 2020 | $1.06M | $939.00K | 0.89% |
| Aug 5, 2020 | Jun 2020 | $1.23M | $488.00K | 0.40% |
| May 7, 2020 | Mar 2020 | $1.31M | $1.26M | 0.96% |
| Mar 11, 2020 | Dec 2019 | $1.13M | $884.00K | 0.78% |
| Nov 12, 2019 | Sep 2019 | $1.16M | $984.00K | 0.85% |
| Aug 12, 2019 | Jun 2019 | $1.13M | $1.15M | 1.02% |
| May 13, 2019 | Mar 2019 | $960.00K | $1.35M | 1.40% |
| Mar 28, 2019 | Dec 2018 | $1.42M | $1.09M | 0.77% |
| Nov 14, 2018 | Sep 2018 | $1.50M | $96.00K | 0.06% |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 10, 2022 | Dec 2021 | $48.04M | $48.21M | 0.36% |
| Mar 11, 2021 | Dec 2020 | $3.89M | $4.04M | 3.78% |
| Mar 11, 2020 | Dec 2019 | $4.37M | $4.37M | -0.11% |
| Mar 28, 2019 | Dec 2018 | $2.70M | $1.19M | -56.04% |
GRTS's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.
Gritstone Oncology's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.
Gritstone Oncology's previous annual earnings date was Mar 10, 2022 for its fiscal year ended Dec 31, 2021.
GRTS's earnings per share (EPS) was $-0.96, beating the consensus analysts forecast of $-1.04 by -7.69% , and higher than the previous year's EPS (Dec 2020) by -65.47%.
Revenues were $48.21M, better than the forecast of $48.04M by 0.36%, and up by 1094.30% from previous year's revenue.
The company reported a net income of $-75.08M.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
